Its involvement in CRC tumorigenesis is nuanced due to its dual functionalities within the WNT signaling pathway‐acting both as an activator (via Lgr5) or a repressor (via BMP4) of WNT target genes.46, 47. The gene discussed is LGR5; the disease is colorectal carcinoma.